January 2016

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed
New Alacare  
New B. Braun Fentanyl  
New Blackmores Vitality Super Greens  
New Dilart HCT  
New Jardiamet  
New Noxicid  
New Zerbaxa  
Revised Andriol Testocaps Indications, Precautions, Adverse Effects
Revised Arcoxia Precautions, Dosage and Administration
Revised Avastin Precautions, Adverse Effects
Revised Axit Pharmacology, Precautions, Interactions with other medicines, Adverse Effects, Dosage and Administration, Overdosage
Revised Biostate Pharmacology, Clinical trials, Indications, Precautions, Adverse Effects, Dosage and Administration, Presentation
Revised Botox Precautions
Revised Fluvax Description
Revised Genotropin Precautions, Adverse Effects, Storage
Revised Mirvaso Presentation
Revised MS Contin Pharmacology, Adverse Effects
Revised MS Mono Adverse Effects
Revised Primacor Adverse Effects
Revised Privigen Description
Revised Sevredol Pharmacology, Adverse Effects
Revised Tamiflu Pharmacology, Clinical  trials
Revised Triumeq Box warnings, Pharmacology, Precautions, Interactions with other medicines, Adverse Effects
Revised Zometa Precautions, Adverse Effects, Presentation

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au